Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

High-dose atorvastatin therapy progressively decreases skeletal muscle mitochondrial respiratory capacity in humans

JCI Insight(2024)10.1172/jci.insight.174125Source: DataRank Database

High-dose atorvastatin therapy progressively decreases skeletal muscle mitochondrial respiratory capacity in humans is a research paper published in JCI Insight (2024). On theSindex it has a DataRank of 0. It has been cited 19 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access19 citations

Download PDF

Cite:

Linked data & code

gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 5.16)OA: goldTopics (35)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Maria J. Torres ORCID,Chien‐Te Lin ORCID,Angela H. Clark,Patricia Brophy,Cheryl A. Smith ORCID

Live enrichment

PubMed:38385748 PMC:PMC10967389 OpenAlex:https://openalex.org/W4391993019

Foundation for the National Institutes of Health

Grant: AR071263

NIGMS NIH HHS

Grant: P20 GM144269

NIAMS NIH HHS

Grant: R01 AR071263

National Institutes of Health

Grant: 3P20GM144269-02S1

Kansas Center for Metabolism and Obesity REsearch (KC-MORE)

National Institutes of Health

Grant: 5R01AR071263-02

Statins: Mitochondrial Function and Aerobic Capacity

FWCI

5.16

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1172/jci.insight.174125

publisherhttps://doi.org/10.1172/jci.insight.174125

publisherhttps://insight.jci.org/articles/view/174125/files/pdf

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38385748

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10967389

Fields of Study

Muscle metabolism and nutritionLipoproteins and Cardiovascular HealthAdipose Tissue and Metabolism0303 health sciences03 medical and health sciences

MeSH Terms

AtorvastatinAdultFemaleHumansMaleMitochondriaMitochondria, MuscleMuscular DiseasesMuscle, SkeletalHydroxymethylglutaryl-CoA Reductase Inhibitors

Keywords

AtorvastatinSkeletal muscleMedicineInternal medicineOxidative phosphorylationEndocrinologyChemistryBiochemistryMitochondriaBioenergeticsMuscle BiologyMaleAdultMuscular DiseasesHumansFemaleClinical MedicineHydroxymethylglutaryl-CoA Reductase InhibitorsMuscle, SkeletalMitochondria, Muscle

Sustainable Development Goals

SDG 0: Zero hunger

High-dose atorvastatin therapy progressively decreases skeletal muscle mitochondrial respiratory capacity in humans

FAIR Checklist

Authors (10)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)